-
Fighting glaucoma in India
Wednesday, March 4, 2020Allergan, Sightsavers and the International Agency for the Prevention of Blindness (IAPB) has announced the launch of a joint initiative – ‘Keep Sight India’
-
Marketing authorisation application
Saturday, February 1, 2020Aerie Pharmaceuticals has submitted the marketing authorisation application (MAA) for Roclanda® (netarsudil and latanoprost ophthalmic solution) 0.02%/0.005% with the European Medicines Agency (EMA). Roclanda® is currently marketed in the US as Rocklatan®.
-
Reimbursement recommendation
Saturday, February 1, 2020Santen Canada Inc., a subsidiary of Santen Pharmaceutical Co., Ltd. has announced that the Canadian Agency for Drugs and Technologies in Health Canadian Drug Expert Committee released a reimbursement recommendation for Verkazia TM (cyclosporine 0.1%) eyedrops.
-
Clinical director
Saturday, February 1, 2020Heidelberg Engineering has appointed Christopher Mody as its Clinical Director.
-
Johnson&Johnson Vision Appointment
Friday, December 13, 2019Johnson & Johnson Vision has announced that Warren Foust will assume the role of Worldwide President, Surgical for Johnson & Johnson Vision, effective December 2, 2019.
-
Sinusoidal Vision Technology
Friday, December 13, 2019VSY Techanology has announced that Acriva Trinova has been registered by the European Patent Office. “In 2018, VSY Biotechnology introduced its next generation Sinusoidal Vision Technology by developing its conventional optical structure,” said a company spokesperson. “An intraocular lens produced with SVT, AcrivaUD Trinova’s Sinusoidal trifocal optic design has been officially registered by the European […]
-
Clinical study services
Friday, November 1, 2019Medeuronet, a medical device consulting firm focused on European market entry, has acquired the clinical study business assets from IROC Science in a private transaction. IROC Science (Zug, Switzerland) will continue to operate, focusing on developing ophthalmology products, collaborating with medeuronet until companies are ready to go to market. “After collaborating on ophthalmology projects over […]
-
New cross-linking technology
Friday, November 1, 2019Avedro showcased early data on its novel Boost Epi-On cross-linking (CXL) technology for the treatment of keratoconus during an educational session at the 37th Congress of the ESCRS in Paris, France. Presentations highlighted the positive early clinical experiences of several clinicians from different countries who have evaluated Boost Epi-On CXL, a non-invasive corneal CXL procedure […]
-
Innovation comes in many forms, helping patients to see better, connect better and live better
Friday, November 1, 2019Johnson & Johnson Vision announced a series of new products and innovations at the 2019 American Academy of Ophthalmology (AAO) Annual Meeting in San Francisco, CA, USA. The company announced the US Food & Drug Administration (FDA) approval of the iDESIGN Refractive Studio Wavefront-guided PRK indication and the availability of TECNIS Simplicity Delivery System. “Innovation […]
-
New office opens in China
Friday, November 1, 2019EyeKor, Inc., an imaging and data management company for the ophthalmic pharmaceutical clinical trial and ocular preclinical laboratory industries, has announced that it is opening a new office in China to enhance its capability to provide local support for clinical trial sponsors and sites in China and the APAC region. “Over the past few years, […]
